Thurston Springer Miller Herd & Titak Inc. Reduces Holdings in Xylem Inc. $XYL

Thurston Springer Miller Herd & Titak Inc. reduced its position in Xylem Inc. (NYSE:XYL) by 91.7% in the 3rd quarter, Holdings Channel reports. The firm owned 1,691 shares of the industrial products company’s stock after selling 18,715 shares during the quarter. Thurston Springer Miller Herd & Titak Inc.’s holdings in Xylem were worth $249,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Maseco LLP acquired a new stake in shares of Xylem in the second quarter valued at about $31,000. ST Germain D J Co. Inc. grew its stake in Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock valued at $33,000 after acquiring an additional 228 shares in the last quarter. Signature Resources Capital Management LLC purchased a new stake in Xylem during the 2nd quarter valued at about $39,000. Caldwell Trust Co acquired a new stake in Xylem in the 2nd quarter valued at about $41,000. Finally, FWL Investment Management LLC purchased a new position in Xylem in the 2nd quarter worth approximately $43,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Insider Activity at Xylem

In related news, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction that occurred on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This trade represents a 9.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. This trade represents a 25.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.27% of the company’s stock.

Xylem Stock Performance

Shares of Xylem stock opened at $137.59 on Wednesday. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $154.27. The business’s fifty day simple moving average is $144.46 and its 200-day simple moving average is $139.31. The firm has a market cap of $33.50 billion, a PE ratio of 35.37, a price-to-earnings-growth ratio of 2.14 and a beta of 1.18. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. During the same period last year, the company earned $1.11 EPS. The company’s quarterly revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Equities analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, November 25th. Xylem’s payout ratio is 41.13%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on XYL shares. Citigroup upped their price target on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Weiss Ratings restated a “buy (b)” rating on shares of Xylem in a report on Monday. Barclays raised their target price on Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Stifel Nicolaus boosted their price target on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Finally, Royal Bank Of Canada raised their price objective on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and an average price target of $167.40.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.